1. Home
  2. BJDX vs AKAN Comparison

BJDX vs AKAN Comparison

Compare BJDX & AKAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BJDX
  • AKAN
  • Stock Information
  • Founded
  • BJDX 2015
  • AKAN 2021
  • Country
  • BJDX United States
  • AKAN United Kingdom
  • Employees
  • BJDX N/A
  • AKAN N/A
  • Industry
  • BJDX Medical Specialities
  • AKAN Medicinal Chemicals and Botanical Products
  • Sector
  • BJDX Health Care
  • AKAN Health Care
  • Exchange
  • BJDX Nasdaq
  • AKAN Nasdaq
  • Market Cap
  • BJDX 2.1M
  • AKAN 2.4M
  • IPO Year
  • BJDX 2021
  • AKAN 2022
  • Fundamental
  • Price
  • BJDX $3.45
  • AKAN $1.75
  • Analyst Decision
  • BJDX
  • AKAN
  • Analyst Count
  • BJDX 0
  • AKAN 0
  • Target Price
  • BJDX N/A
  • AKAN N/A
  • AVG Volume (30 Days)
  • BJDX 43.6K
  • AKAN 120.7K
  • Earning Date
  • BJDX 03-27-2025
  • AKAN 02-28-2025
  • Dividend Yield
  • BJDX N/A
  • AKAN N/A
  • EPS Growth
  • BJDX N/A
  • AKAN N/A
  • EPS
  • BJDX N/A
  • AKAN N/A
  • Revenue
  • BJDX N/A
  • AKAN $2,508,317.00
  • Revenue This Year
  • BJDX N/A
  • AKAN N/A
  • Revenue Next Year
  • BJDX N/A
  • AKAN N/A
  • P/E Ratio
  • BJDX N/A
  • AKAN N/A
  • Revenue Growth
  • BJDX N/A
  • AKAN N/A
  • 52 Week Low
  • BJDX $3.03
  • AKAN $1.22
  • 52 Week High
  • BJDX $386.80
  • AKAN $47.52
  • Technical
  • Relative Strength Index (RSI)
  • BJDX 45.28
  • AKAN 56.48
  • Support Level
  • BJDX $3.37
  • AKAN $1.46
  • Resistance Level
  • BJDX $3.83
  • AKAN $1.78
  • Average True Range (ATR)
  • BJDX 0.24
  • AKAN 0.10
  • MACD
  • BJDX -0.00
  • AKAN 0.00
  • Stochastic Oscillator
  • BJDX 24.00
  • AKAN 65.91

About BJDX Bluejay Diagnostics Inc.

Bluejay Diagnostics Inc is a medical diagnostics company. It is developing rapid tests using whole blood using its Symphony technology platform to improve patient outcomes in critical care settings. The company's first product, the Symphony IL-6 test, is for the monitoring of disease progression in critical care settings and is a clinically established inflammatory biomarker for the assessment of the severity of infection and inflammation across many disease indications, including sepsis.

About AKAN Akanda Corp.

Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The Company has three reportable segments: Cultivation, Distribution, and Corporate. Cultivating activities comprise the cultivation segment made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom. Corporate activities entail head office costs and other general corporate expenses related to the administration of the broader group.

Share on Social Networks: